Evidence map›Paper›PMID 41807778›Full record

ArticleArchives of toxicology2026

In vitro toxicity assessment of graphene quantum dots using a 3D HepG2 model.

Irma Durmišević, Anja Haverić, Sonja Žabkar, Alja Štern, Katja Kološa, Petra Jenuš Belec, Tamara Ćetković Pećar, Maida Hadžić Omanović, Sanjin Gutić, Iza Rozman and 2 more

Abstract read
In one paragraph

Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Irma DurmiševićInstitute for Genetic Engineering and Biotechnology, University of Sarajevo, Zmaja od Bosne 8, Sarajevo, Bosnia and Herzegovina.
Anja HaverićInstitute for Genetic Engineering and Biotechnology, University of Sarajevo, Zmaja od Bosne 8, Sarajevo, Bosnia and Herzegovina.
Sonja ŽabkarDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 121, Ljubljana, Slovenia.
Alja ŠternDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 121, Ljubljana, Slovenia.
Katja KološaDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 121, Ljubljana, Slovenia.
Petra Jenuš BelecDepartment for Nanostructural Materials, Jožef Stefan Institute, Jamova cesta 39, Ljubljana, Slovenia.
Tamara Ćetković PećarInstitute for Genetic Engineering and Biotechnology, University of Sarajevo, Zmaja od Bosne 8, Sarajevo, Bosnia and Herzegovina.
Maida Hadžić OmanovićInstitute for Genetic Engineering and Biotechnology, University of Sarajevo, Zmaja od Bosne 8, Sarajevo, Bosnia and Herzegovina.
Sanjin GutićFaculty of Science, University of Sarajevo, Zmaja od Bosne 33-35, Sarajevo, Bosnia and Herzegovina.
Iza RozmanDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 121, Ljubljana, Slovenia.
Sanin HaverićInstitute for Genetic Engineering and Biotechnology, University of Sarajevo, Zmaja od Bosne 8, Sarajevo, Bosnia and Herzegovina.
Bojana ŽeguraDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 121, Ljubljana, Slovenia. bojana.zegura@nib.si.ORCID 0000-0002-5731-0785

Funding

Federal Ministry of Education and Science 05-35-2670-/23HORIZON EUROPE Framework Programme 101079113Javna Agencija za Raziskovalno Dejavnost RS BI-BA/24-25-27Javna Agencija za Raziskovalno Dejavnost RS J1-2465,Javna Agencija za Raziskovalno Dejavnost RS J1-4395Javna Agencija za Raziskovalno Dejavnost RS MR IRJavna Agencija za Raziskovalno Dejavnost RS P1-0245Javna Agencija za Raziskovalno Dejavnost RS P2-0087Ministry of Science, Higher Education, and Youth of Sarajevo Canton 27-02-11-41250-2/21Ministry of Science, Higher Education, and Youth of Sarajevo Canton 27-02-35-37082-38/23
6 · The paper itself

Abstract

In the present study, two types of graphene quantum dots (GQDs) were investigated: green-emitting (G-GQDs) and blue-emitting (B-GQDs). Physicochemical characterisation was performed using transmission electron microscopy (TEM), zeta potential, and hydrodynamic radius measurements to evaluate the morphology, particle size, aggregation behaviour, and colloidal stability of the GQDs in both water and cell culture medium. G-GQDs exhibited superior colloidal stability and more uniform dispersion than B-GQDs, whereas both types showed reduced aggregation and surface charge in cell culture medium due to protein corona formation. Toxicological characterisation was performed using an in vitro human hepatocellular carcinoma (HepG2) 3D spheroid model, with GQDs exposures up to 250 µg/mL (100 µg/cm2). Cytotoxicity was measured using the CellTiter-Glo luminometric assay, while genotoxicity was evaluated by the comet assay and flow cytometric analysis of γH2AX and phosphorylated histone H3 (p-H3) after 24 h of exposure. Both GQDs induced dose-dependent cytotoxic effects in HepG2 spheroids. At non-cytotoxic concentrations, a dose-dependent increase in DNA damage was observed, as determined by the comet assay. However, no evidence of DNA double-strand breaks (γH2AX) or elevated p-H3 levels was detected, suggesting the absence of clastogenic and aneugenic activity. The observed DNA single-strand breaks may be partly attributed to reactive oxygen species induction. These results indicate that, although GQDs induced cytotoxicity and single-strand DNA damage, no clear evidence of more severe genotoxic effects was observed under the tested conditions. Further studies are warranted to elucidate underlying mechanisms and comprehensively assess the safety profile of GQDs for biomedical applications.

Indexed as

GraphiteQuantum DotsCarbon Quantum DotsCell SurvivalComet AssayDNA DamageDose-Response Relationship, DrugHep G2 CellsHistonesHumansMicroscopy, Electron, TransmissionParticle SizeSpheroids, CellularToxicity TestsGraphiteH2AX protein, humanHistonesGraphene quantum dotsHepG2 spheroidsNanomaterialsToxicity

Identifiers

PMID41807778
PMCPMC13221323

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.